Oak Longevity vs IVIM Health: low price vs clinician protocol
Oak Longevity vs IVIM Health: which telehealth GLP-1 provider fits you? Quick verdict: Oak Longevity is the lower-cost, no-subscription option with free shipping and coaching, while IVIM Health emphasizes a clinician-guided protocol and unusually strong third-party ratings.
Explore Oak Longevity pricing from $133/mo
How they differ at a glance
This comparison focuses on the most distinctive supported differences: price and pricing model, clinician-guided protocol and outcomes claims, third-party ratings and trust signals, membership and fee structures, and how clinical review and dispensing are handled. The primary keyword Oak Longevity vs IVIM Health appears here so searchers find this direct comparison quickly.
1. Price and pricing model
Oak Longevity lists semaglutide starting at $133/month and tirzepatide from $199/month with one flat price covering all dosages and no subscription or membership fees. IVIM Health advertises semaglutide at $75/mo and tirzepatide at $133/mo on some landing content, but also discloses a program fee and a first-month promotional structure with ongoing pricing rising to $174/month per the FAQ. IVIM also offers a GIFT75 free-month-membership code.
Check IVIM Health’s GIFT75 offer and program details
2. Clinician-guided protocol and outcome claims
IVIM Health promotes a proprietary GLP-1 ID protocol and cites internal study findings that patients following the IVIM Protocol lost an average of 46% more weight over 68 weeks compared to another published clinical GLP-1 trial. IVIM also claims its GLP-1 ID can accelerate weight loss by up to 40% versus standard protocols. These are proprietary or internal protocol claims and are not head-to-head randomized trial results per the source. Oak Longevity does not present an outcome comparison or proprietary protocol claim; its emphasis is on pricing and access.
3. Third-party validation and trust signals
IVIM Health reports a 4.9-star rating on both Google and Trustpilot, described as a rare dual third-party verification and a key trust signal. Oak Longevity highlights more than 10,000 patients served and board-certified physicians in your state reviewing cases, but does not present the dual 4.9-star external ratings in the supplied evidence.
4. Membership, fees, and billing details
Oak Longevity: no subscriptions, no membership fees, billed monthly on a non-recurring basis so you are not auto charged and you choose to renew payment each month. Three-month prescriptions are billed upfront and Oak states no refunds after physician approval and once medication has shipped. IVIM Health: offers a free month membership code GIFT75 and a no-obligation free consultation valued at $75 for new patients; IVIM’s ongoing pricing is presented as $174/month after promotional periods and it discloses a program fee structure.
5. Clinical review and compounded medication notes
Oak Longevity conducts asynchronous clinical review with no video call required and board-certified physicians review every case. Oak offers compounded semaglutide and tirzepatide and explicitly notes compounded medications are not FDA-approved finished products. IVIM Health prescribes compounded GLP-1 medications only after consultation with an IVIM provider, states compounded drugs are not FDA-approved and have not undergone FDA review, and uses independent licensed compounding pharmacies. IVIM also emphasizes ongoing supervision of compounded medications by its providers.
| Criteria | Oak Longevity | IVIM Health |
|---|---|---|
| Starting price | Semaglutide from $133/mo; tirzepatide from $199/mo | Landing content shows semaglutide $75/mo and tirzepatide $133/mo; FAQ lists $99 first month and $174/mo ongoing; GIFT75 free month |
| Pricing model | One flat price for all dosages; billed monthly non-recurring | First-month promotions and a program fee; ongoing monthly rate disclosed |
| Membership and fees | No subscriptions or membership fees | Free month with code GIFT75; program fee and promotional consult value |
| Clinical review | Asynchronous review; no video call required; board-certified physicians review cases | Clinician-guided protocol with consultation; weekly dose adjustments under supervision |
| Third-party ratings | 10,000+ patients served noted; no dual 4.9-star claim in source | 4.9-star rating on both Google and Trustpilot per source |
| Compounded medication note | Compounded medications not FDA-approved finished products | Compounded medications not FDA-reviewed; prepared by licensed compounding pharmacies |
See Oak Longevity’s no-subscription plans
What this means for patients choosing Oak Longevity vs IVIM Health
If you prioritize lower published starting prices, a single flat fee across dosages, no subscription or membership, and an asynchronous clinician review without a required video call, Oak Longevity matches those priorities directly. If you prioritize a structured, clinician-guided protocol with published internal outcomes claims and unusually strong third-party ratings, IVIM Health emphasizes that approach while using promotional codes and membership offers to lower initial cost.
Start Oak Longevity enrollment
Final thoughts on Oak Longevity vs IVIM Health
Oak Longevity vs IVIM Health boils down to price and access versus a clinician-optimized program and dual external ratings. Both prescribe compounded GLP-1 medications and both note compounded drugs are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. Specific clinical results and state availability are not provided beyond each provider’s statements in the source.
Choose Oak Longevity if you want lower advertised starting prices, one flat price for all dosages, no subscription or membership fees, free shipping and health coaching, and an asynchronous clinical review process. Choose IVIM Health if you want a proprietary clinician-guided GLP-1 ID protocol, strong third-party ratings, and promotional membership offers like GIFT75 and a no-obligation consultation.